首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   120篇
  免费   29篇
  149篇
  2022年   2篇
  2021年   3篇
  2019年   4篇
  2018年   3篇
  2017年   1篇
  2016年   5篇
  2015年   6篇
  2014年   7篇
  2013年   3篇
  2012年   3篇
  2011年   3篇
  2010年   4篇
  2009年   2篇
  2008年   3篇
  2007年   2篇
  2006年   1篇
  2005年   1篇
  2004年   2篇
  2003年   4篇
  2002年   4篇
  2001年   4篇
  2000年   8篇
  1999年   9篇
  1998年   6篇
  1997年   2篇
  1996年   3篇
  1994年   3篇
  1992年   3篇
  1991年   5篇
  1990年   3篇
  1989年   2篇
  1988年   1篇
  1987年   8篇
  1986年   4篇
  1985年   1篇
  1984年   2篇
  1983年   1篇
  1982年   4篇
  1981年   2篇
  1978年   1篇
  1976年   2篇
  1973年   2篇
  1970年   2篇
  1969年   1篇
  1968年   1篇
  1930年   1篇
  1929年   1篇
  1928年   1篇
  1923年   1篇
  1921年   1篇
排序方式: 共有149条查询结果,搜索用时 15 毫秒
131.
Human transferrin (Tf) is responsible for the binding and transport of iron in the bloodstream of vertebrates. Delivery of this bound iron to cells occurs by a process of receptor-mediated endocytosis during which Tf releases its iron at the reduced endosomal pH of approximately 5.6. Iron release from Tf involves a large conformational change in which the two domains that enclose the binding site in each lobe move apart. We have examined the role of two lysines, Lys206 and Lys296, that form a hydrogen-bonded pair close to the N-lobe binding site of human Tf and have been proposed to form a pH-sensitive trigger for iron release. We report high-resolution crystal structures for the K206A and K296A mutants of the N-lobe half-molecule of Tf, hTf/2N, and quantitative iron release data on these mutants and the double mutant K206A/K296A. The refined crystal structures (for K206A, R = 19.6% and R(free) = 23.7%; for K296A, R= 21.2% and R(free) = 29.5%) reveal a highly conserved hydrogen bonding network in the dilysine pair region that appears to be maintained even when individual hydrogen bonding groups change. The iron release data show that the mutants retain iron to a pH 1 unit lower than the pH limit of wild type hTf/2N, and release iron much more slowly as a result of the loss of the dilysine interaction. Added chloride ions are shown to accelerate iron release close to the pH at which iron is naturally lost and the closed structure becomes destabilized, and to retard it at higher pH.  相似文献   
132.
As translational clinical researchers familiar with the risk-benefit of hematopoietic stem cell transplantation in autoimmune diseases, we are intrigued by the recent report of umbilical cord mesenchymal stem cell (UC-MSC) transplantation in treatment-refractory systemic lupus erythematosus nephritis by Wang and colleagues. They report the results of an open-label single-arm multicenter phase I/II study. This stimulated us to examine whether collective data from this group provide sufficient evidence for the feasibility, safety, dose rationale, and potential efficacy of UC-MSCs to conduct a randomized controlled trial in such patients. Results, though confounded by variable baseline prednisone and immuno-suppressive treatment, appear to indicate near-term response rates of approximately 50%, which are comparable to those seen with hematopoietic stem cell transplantation but with less morbidity and mortality.Wang and colleagues have been in the forefront of evaluating the potential for mesenchymal stem cells (MSCs) to treat systemic lupus erythematosus (SLE), based on studies in murine autoimmune disease models, demonstrating immunomodulatory properties of MSCs [1]. We have reviewed the additional reports published in peer-reviewed journals from this group [25], together with two protocols available on ClinicalTrials.gov (NCT00698191 and NCT01741857) (Table 
Authors (date)ClinicalTrials.gov protocol numberStudy design/duration of follow-upNumber of patientsMSC type/regimenConditioningSafety: deaths/serious infectionPD marker a Efficacy
Sun et al. [2]NRSingle-arm/ median of 8.25 months (range of 3 to 28 months)16 (15 SLEN)UC, single infusionCYC 0.8 to 1.8 mg/kg intravenously, 2 to 4 days0/0Percentage of Treg cells increased at 3 months (P = 0.03)‘Decreasing SLEDAI and proteinuriab in all patients’
Liang et al. [3]NCT 00698191Single-arm/17.2 ± 9.5 months15 SLENBM, single infusionIncluded in protocol, but NR0/0Percentage of Treg cells increased at 1 week and 3 and 6 months (P <0.05)‘Decreasing SLEDAI and proteinuriab in all patients’
Wang et al. [4]NCT 00698191Unblinded-randomized, 2-arm/12 months58 (~88% SLEN)BM, UC, single versus 2× (7 days apart)CYC 10 mg/kg per day, day 4, 3, and 21/NRNDCR single: 16/30 (53%); double: 8/27 (29%)
Wang et al. [5]NRSingle-arm/mean of 27 months87 (84% SLEN)BM, UC, single infusion, 18 patients retreated at relapseCYC 10 mg/ kg/day, day 4, 3, and 25/NRNDCR in 23/83, relapse 10/83
Wang et al. [1] cNCT 01741857Single-arm40 (38 SLEN)UC, 2× infusion, 7 days apart)No3/4NDMCR 13/PCR 11, 7 relapse
Open in a separate window aPharmacodynamic (PD) markers = increased peripheral blood regulatory T (Treg) cells, balanced T helper 1 (Th1)/Th2 cytokines; b [2] baseline (BL) proteinuria 3.1 (±1.2) g/day versus 3 months, 1.3 (±0.9) g/day (P <0.001, n = 15); [3] BL proteinuria 2.7 (±1.2) g/day versus 6 months, 0.9 (±0.8) g/day (P <0.01, n = 12); cprotocol described at ClinicalTrials.gov consistent with this study, but not explicitly noted in report. BM, bone marrow; CR, complete remission; CYC, cyclophosphamide; MCR, major clinical response; MSC, mesenchymal stem cell; ND, not done; NR, not reported; PCR, partial clinical response; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index; SLEN, systemic lupus erythematosus nephritis; UC, umbilical cord.Protocol NCT01741857, first posted on 26 November 2012 and updated 1 November 2013, appears to be the protocol for the study recently published in Arthritis Research & Therapy [1]. The report largely reflects the protocol, although dose is not described and patient entry criteria required a dose of prednisone of more than 20 mg/day. In the report, only 10 of 40 patients were receiving prednisone of more than 20 mg/day, and one dose - 1 × 106 cells per kg, infused twice 7 days apart - was evaluated. The umbilical cord mesenchymal stem cells (UC-MSCs) for infusion were centrally prepared by using a well-standardized, quality-controlled method, and infusions were well tolerated. One-year mortality (two patients with uncontrolled SLE) and morbidity (five serious infections) compare favorably to those seen with hematopoietic stem cell transplantation in patients with SLE [6].Previously reported studies by this group [25] evaluated stem cells derived from either bone marrow of healthy relatives or umbilical cords donated by healthy consenting mothers in patients with treatment-refractory SLE. Most patients had active SLE nephritis despite receiving prednisone of more than 20 mg and immuno-suppression with cyclophosphamide, mycophenylate mofetil, or leflunomide or a combination of these. In addition, they usually received ‘conditioning’ by cyclophosphamide 0.8 to 1.8 mg/kg per day for 3 days prior to transplant. In contrast, in the recently reported study [1], only UC-MSCs were transplanted, without ‘conditioning’, in patients with active treatment-refractory SLE nephritis receiving a more variable background of prednisone, often less than 20 mg/day, and immunosuppression. Although efficacy is difficult to evaluate because major clinical response (MCR) required that prednisone be tapered to less than 10 mg/day, while maintaining improvements in disease activity measured by British Isles Lupus Assessment Group and Systemic Lupus Erythematosus Disease Activity Index, conditioning is apparently not needed. However, because 18 of 40 patients were receiving prednisone of less than 20 mg/day at the start of the study, the efficacy criterion of ‘tapered’ prednisone is difficult to assess. Although 24 responses - 13 MCR and 11 partial clinical response (CR) - are reported, 6 MCR and 6 partial CR cannot be verified in the reported data, because prednisone tapering appears not to meet criteria for response. In addition, relapse occurred within a year in 6 patients, most receiving at least 20 mg prednisone at baseline. Nevertheless, there may be some evidence for potential efficacy or perhaps corticosteroid sparing, but dose regimen results are not sufficiently clear, or defined by relevant pharmacodynamic activity, to identify a specific UC-MSC dose to use for a randomized controlled trial (RCT).Review of previous reports may provide some additional insight (Table 4]. In the same study, patients were randomly assigned in an unblinded manner to receive a single infusion versus two infusions of MSC, 7 days apart; again, no significant difference in CR rate was observed. Of interest are two studies that reported (Table 2, 3]. No correlations with improvement in clinical status were reported, however.Overall, Wang and colleagues have demonstrated the feasibility of a multicenter trial, as they apparently recruited a sufficient number of patients in a reasonable period of time, and safety was acceptable. Apparently, conditioning pre-MSC dosing is not required, although this aspect of the treatment has not been studied in a controlled manner. It should be pointed out that the collective published results may reflect the fact that some of the same patients were reported in more than one study. For example, two publications [1, 4] refer to the same NCT00698191 protocol; thus, recruitment feasibility may be optimistic. The dose of stem cells, with biologic activity shown in two studies, may have been defined, although it is not absolutely clear (see above caveats). There are also some indications of an appropriate population, but again there seems to be some lack of clarity based on the recently published study [1] where the endpoints were not actually met.The lack of a well-rationalized dosing regimen, together with a lack of results from an appropriately designed, well-controlled study, makes it extremely difficult to develop a treatment approach with UC-MSCs. Nevertheless, we feel that these results should not be discarded without a proper RCT. Although there may be some challenges in designing a well-controlled, double-blind, placebo-controlled RCT in patients with prednisone-dependent active SLE nephritis, this should be attempted [7].  相似文献   
133.
Structure–activity relationships of norepinephrine reuptake inhibitors with benzothiadiazine dioxide or dihydrosulfostyril cores     
Andrew Fensome  Joel Goldberg  Casey C. McComas  Eugene J. Trybulski  Richard P. Woodworth  Darlene C. Deecher  Garth T. Whiteside  Puwen Zhang 《Bioorganic & medicinal chemistry letters》2010,20(5):1555-1558
Two related series of selective norepinephrine reuptake inhibitors were synthesized based on 3,4-dihydro-1H-2,1,3-benzothiadiazine 2,2-dioxide or 3,4-dihydrosulfostyril cores, and screened for monoamine reuptake inhibition. Structure–activity relationships were determined for the series’ in vitro potency and selectivity versus serotonin or dopamine transporter inhibition, and analogs based on both cores were identified as potent and selective NRIs. The 3,4-dihydrosulfostyril series was further tested for microsome stability, and compound 16j, which was optimized for both potency and stability, showed efficacy in an in vivo model of thermoregulatory dysfunction.  相似文献   
134.
Wild Birds Learn Songs from Experimental Vocal Tutors     
Daniel J. Mennill  Stéphanie M. Doucet  Amy E.M. Newman  Heather Williams  Ines G. Moran  Ian P. Thomas  Bradley K. Woodworth  D. Ryan Norris 《Current biology : CB》2018,28(20):3273-3278.e4
135.
Relationship among location of T-antigen-induced DNA distortion,auxiliary sequences,and DNA replication efficiency          下载免费PDF全文
Okuley S  Call M  Mitchell T  Hu B  Woodworth ME 《Journal of virology》2003,77(19):10651-10657
T-antigen-induced DNA distortion was studied in a series of simian virus 40 (SV40) plasmid constructs whose relative replication efficiency ranges from 0.2 to 36. Bending was detected in the wild-type SV40 regulatory region consisting of three copies of the GC-rich 21-bp repeat but not in constructs with only one or two copies of the 21-bp repeat. In a construct with enhanced replication efficiency, bending occurred in a 69-bp cellular sequence located upstream of a single copy of the 21-bp repeat. Bending occurred both upstream of ori and in the three 21-bp repeats located downstream of ori in a construct with reduced replication efficiency. In a construct with no 21-bp repeats, DNA distortion occurred downstream of ori. The results indicate that SV40 DNA replication is enhanced when the structure of the regulatory region allows the DNA to form a bent structure upstream of the initial movement of the replication fork.  相似文献   
136.
Climate change is projected to reduce carrying capacity and redistribute species richness in North Pacific pelagic marine ecosystems     
Phoebe A. Woodworth‐Jefcoats  Jeffrey J. Polovina  Jeffrey C. Drazen 《Global Change Biology》2017,23(3):1000-1008
Climate change is expected to impact all aspects of marine ecosystems, including fisheries. Here, we use output from a suite of 11 earth system models to examine projected changes in two ecosystem‐defining variables: temperature and food availability. In particular, we examine projected changes in epipelagic temperature and, as a proxy for food availability, zooplankton density. We find that under RCP8.5, a high business‐as‐usual greenhouse gas scenario, increasing temperatures may alter the spatial distribution of tuna and billfish species richness across the North Pacific basin. Furthermore, warmer waters and declining zooplankton densities may act together to lower carrying capacity for commercially valuable fish by 2–5% per decade over the 21st century. These changes have the potential to significantly impact the magnitude, composition, and distribution of commercial fish catch across the pelagic North Pacific. Such changes will in turn ultimately impact commercial fisheries’ economic value. Fishery managers should anticipate these climate impacts to ensure sustainable fishery yields and livelihoods.  相似文献   
137.
Mechanism of microwave sterilization in the dry state     
D K Jeng  K A Kaczmarek  A G Woodworth  G Balasky 《Applied and environmental microbiology》1987,53(9):2133-2137
With an automated computerized temperature control and a specialized temperature measurement system, dry spores of Bacillus subtilis subsp. niger were treated with heat simultaneously in a convection dry-heat oven and a microwave oven. The temperature of the microwave oven was monitored such that the temperature profiles of the spore samples in both heat sources were nearly identical. Under these experimental conditions, we unequivocally demonstrated that the mechanism of sporicidal action of the microwaves was caused solely by thermal effects. Nonthermal effects were not significant in a dry microwave sterilization process. Both heating systems showed that a dwelling time of more than 45 min was required to sterilize 10(5) inoculated spores in dry glass vials at 137 degrees C. The D values of both heating systems were 88, 14, and 7 min at 117, 130, and 137 degrees C, respectively. The Z value was estimated to be 18 degrees C.  相似文献   
138.
139.
Complex binding interactions between multicomponent mixtures and odorant receptors in the olfactory organ of the Caribbean spiny lobster Panulirus argus     
Gentilcore  LR; Derby  CD 《Chemical senses》1998,23(3):269-281
Our study was designed to examine how components of complex mixtures can inhibit the binding of other components to receptor sites in the olfactory system of the spiny lobster Panulirus argus. Biochemical binding assays were used to study how two- to six-component mixtures inhibit binding of the radiolabeled odorants taurine, L-glutamate and adenosine-5'-monophosphate to a tissue fraction rich in dendritic membrane of olfactory receptor neurons. Our results indicate that binding inhibition by mixtures can be large and is dependent on the nature of the odorant ligand and on the concentration and composition of the mixture. The binding inhibition by mixtures of structurally related components was generally predicted using a competitive binding model and binding inhibition data for the individual components. This was not the case for binding inhibition by most mixtures of structurally unrelated odorants. The binding inhibition for these mixtures was generally smaller than that for one or more of their components, indicating that complex binding interactions between components can reduce their ability to inhibit binding. The magnitude of binding inhibition was influenced more by the mixture's precise composition than by the number of components in it, since mixtures with few components were sometimes more inhibitory than mixtures with more components. These findings raise the possibility that complex binding interactions between components of a mixture and their receptors may shape the output of olfactory receptor neurons to complex mixtures.   相似文献   
140.
[首页] « 上一页 [6] [7] [8] [9] [10] [11] [12] [13] 14 [15] 下一页 » 末  页»
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号